Cerebral Oxygenation During Vojta Therapy in Healthy Adults Using Near-infrared Spectroscopy

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05170906

Enrollment

Registered

2021-12-28

Start date

2022-04-01

Completion date

2022-12-01

Last updated

2022-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain, Healthy

Keywords

Adult, Vojta Therapy, Oxigenation

Brief summary

A randomized clinical trial on a cohort of healthy subjects of legal age, both sexes, recruited from the university community and who will be randomly distributed into two groups (experimental and control). The objective is to assess neurophysiological activation by measuring oxygenation in the supplementary motor and premotor areas of oxygenation in the supplementary motor and premotor areas, through near infrared spectroscopy (NIRS) in healthy subjects spectroscopy (NIRS) in healthy subjects during the application of Vojta Therapy.

Interventions

OTHERReflex locomotion stimulus

The therapy consists of the application of a stimulating pressure in the pectoral area in the pattern of the locomotion complex of reflex rolling in its first phase. For this, the subject will be placed in a supine position aligned with respect to the axial axis, with the arms along the body, the lower extremities in extension, and the head extended with a rotation of approximately 30º towards one side of the stimulation. The manual stimulation pressure will be exerted in the space between the 6th-7th or the 7th-8th rib under the mammillary line, with a force of about 2 kg.

OTHERsham stimulus

The control group will receive an application in an area with low receptor density located on the thigh, with a force of about 2 kg.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

BASIC_SCIENCE

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

* Over 18 years old. * Under 40 years old. * Full cognitive capacity.

Exclusion criteria

* Subjects with neuro-muscular pathologies that affect the abdominal muscles, previous surgeries in the area or any chronic neurological or organic disorder that may alter the results. * Vaccinated in the 10 days prior to the intervention * Fever

Design outcomes

Primary

Measure	Time frame	Description
Near Infrared Spectroscopy (NIRS)	15 minutes per patients	NIRS power

Countries

Spain

Contacts

Primary ContactJuan Luis S Sánchez González, PhD

juanluissanchez@usal.es660738949

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026